ArticleCureus2025
Current Trends in Antibiotic Therapy and Resistance: A Comparative Study of Various Spectrums.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The global public health concern posed by antibiotic resistance is threatening the usefulness of existing therapies. This calls for an urgent reconsideration of the contemporary trends in antibiotic usage. This study compares narrow-, broad-, and extended-spectrum antibiotics to elucidate resistance patterns, evaluate the therapeutic outcomes, and suggest new ways for combating resistance. Methods The research was analyzed based on 1,050 observations of demographic, clinical, diagnostic, laboratory, and therapeutic parameters. The analysis of effectiveness, safety, and resistance rates was statistically evaluated across different antibiotic spectra and healthcare settings. Results According to reviews of recorded patient entries encompassing 1,050 files, broad-spectrum antibiotics distributed by pharmacies, particularly ceftriaxone (27.9%), were mostly medically prescribed. A history of previous infections was reported in 67.5% of the patients. The antibiotics ceftriaxone and penicillin were the most widely used. The patient care was equally divided into standalone, community based, and hospital based. High-dose drugs were administered to 36.5% of patients; on average, treatment effectiveness is 77.43% with safety rates of 84.77%. The average diagnosis delay was four days. Most of the identified agents were
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.